FDA withdraws approval of Mysoline suspension drug application
The Food and Drug Administration withdrew approval of the new drug application for Mysoline suspension held by FHTA LLC, following the company's agreement
The Food and Drug Administration withdrew approval of the new drug application for Mysoline suspension held by FHTA LLC, following the company's agreement